Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases. / Markey, Keira A; Uldall, Maria; Botfield, Hannah; Cato, Liam D.; Miah, Mohammed A.L.; Hassan-Smith, Ghaniah; Jensen, Rigmor H.; Gonzalez, Ana M; Sinclair, Alexandra J.
I: Journal of Pain Research, Bind 9, 2016, s. 223-232.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases
AU - Markey, Keira A
AU - Uldall, Maria
AU - Botfield, Hannah
AU - Cato, Liam D.
AU - Miah, Mohammed A.L.
AU - Hassan-Smith, Ghaniah
AU - Jensen, Rigmor H.
AU - Gonzalez, Ana M
AU - Sinclair, Alexandra J
PY - 2016
Y1 - 2016
N2 - Idiopathic intracranial hypertension (IIH) results in raised intracranial pressure (ICP) leading to papilledema, visual dysfunction, and headaches. Obese females of reproductive age are predominantly affected, but the underlying pathological mechanisms behind IIH remain unknown. This review provides an overview of pathogenic factors that could result in IIH with particular focus on hormones and the impact of obesity, including its role in neuroendocrine signaling and driving inflammation. Despite occurring almost exclusively in obese women, there have been a few studies evaluating the mechanisms by which hormones and adipokines exert their effects on ICP regulation in IIH. Research involving 11β-hydroxysteroid dehydrogenase type 1, a modulator of glucocorticoids, suggests a potential role in IIH. Improved understanding of the complex interplay between adipose signaling factors such as adipokines, steroid hormones, and ICP regulation may be key to the understanding and future management of IIH.
AB - Idiopathic intracranial hypertension (IIH) results in raised intracranial pressure (ICP) leading to papilledema, visual dysfunction, and headaches. Obese females of reproductive age are predominantly affected, but the underlying pathological mechanisms behind IIH remain unknown. This review provides an overview of pathogenic factors that could result in IIH with particular focus on hormones and the impact of obesity, including its role in neuroendocrine signaling and driving inflammation. Despite occurring almost exclusively in obese women, there have been a few studies evaluating the mechanisms by which hormones and adipokines exert their effects on ICP regulation in IIH. Research involving 11β-hydroxysteroid dehydrogenase type 1, a modulator of glucocorticoids, suggests a potential role in IIH. Improved understanding of the complex interplay between adipose signaling factors such as adipokines, steroid hormones, and ICP regulation may be key to the understanding and future management of IIH.
KW - 11beta-hydroxysteroid dehydrogenase type 1
KW - Leptin
KW - Obesity
KW - Steroid and adipokines
U2 - 10.2147/JPR.S80824
DO - 10.2147/JPR.S80824
M3 - Review
C2 - 27186074
AN - SCOPUS:84964555208
VL - 9
SP - 223
EP - 232
JO - Journal of Pain Research
JF - Journal of Pain Research
SN - 1178-7090
ER -
ID: 179126339